HIV

A Cologne-based research collaboration has found a way to predict the effect of broadly neutralizing antibodies (bnAbs) on the growth rate of HIV-1. This finding is the result of a research collaboration among scientists from the University of Cologne’s Institute for Biological Physics and the Insti more

Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules that help shield HIV from the immune system. Mapping these shields will give researchers a more complete understanding of why antibod more

An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published August 13 in the open-access journal PLOS Pathogens by Postdoctoral Fellow more

by Kristof Theys, Alison F. Feder, Maoz Gelbart, Marion Hartl, Adi Stern, Pleuni S. Pennings HIV has a high mutation rate, which contributes to its ability to evolve quickly. However, we know little about the fitness costs of individual HIV mutations in vivo, their distribution and the different more

Viruses, Vol. 10, Pages 348: Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products Viruses doi: 10.3390/v10070348 Authors: Khumoekae Richard David E. Williams E. Dilip de Silva Mark A. Brockman Zabrina L. Brumme Raymond J. Andersen Ian more

Viruses, Vol. 10, Pages 345: Delivering Phage Products to Combat Antibiotic Resistance in Developing Countries: Lessons Learned from the HIV/AIDS Epidemic in Africa Viruses doi: 10.3390/v10070345 Authors: Tobi E. Nagel The antimicrobial resistance (AMR) crisis and HIV/AIDS epidemic ex more